Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
about
Tyrosine kinase inhibitors for unresectable hepatocellular carcinoma in adultsRole of sorafenib in the treatment of advanced hepatocellular carcinoma: An updateMetabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential linkMultidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinomaTransarterial radioembolization for hepatocellular carcinoma: a reviewRadiotherapy as valid modality for hepatocellular carcinoma with portal vein tumor thrombosisPersonalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker SelectionHow to Improve Therapeutic Ratio in Radiotherapy of HCCProgress in systemic therapy of advanced hepatocellular carcinomaDiabetes mellitus and metformin in hepatocellular carcinomaYttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature ReviewUsefulness of staging systems and prognostic scores for hepatocellular carcinoma treatmentsLactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something NewNew advances in hepatocellular carcinomaA concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of playHepatocellular carcinoma: Where are we?Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenibMolecularly targeted therapy for advanced hepatocellular carcinoma - a drug development crisis?Brazilian society of hepatology recommendations for the diagnosis and treatment of hepatocellular carcinomaHepatocellular Carcinoma in Pakistan: National Trends and Global PerspectiveTransarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and futureTreatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive reviewCurrent Status of Hepatic Arterial Infusion ChemotherapyHepatobiliary Tumors: Update on Diagnosis and ManagementThe Role of Autophagy in Hepatocellular CarcinomaSorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studiesHepatocellular Carcinoma and Liver Transplantation: State of the ArtWhat links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatmentHepatocellular carcinoma: From clinical practice to evidence-based treatment protocolsEvaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imagingPredictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging systemPotentiality of immunotherapy against hepatocellular carcinomaSub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomasGenetic and epigenetic aspects of initiation and progression of hepatocellular carcinomaMultimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular CarcinomaOptimal combination of antiangiogenic therapy for hepatocellular carcinomaBiological features and biomarkers in hepatocellular carcinomaCurrent and future treatments for hepatocellular carcinoma
P2860
Q24187730-937D185C-7864-44D5-A6BC-C88CB9566C14Q24619987-0A655A42-B08A-4317-93CA-45E51AD8ACEAQ24631619-D354487C-3A10-443A-B8A5-CA5F6C520640Q24635267-113859C2-4513-4757-9CAD-FB15D64545ACQ26738273-BA2EDCED-81CF-49B9-875B-004B96349F53Q26738533-5E6797A7-DC0A-4618-91A7-0ED9A9908F70Q26738860-4210F80B-78A2-44CA-AE8D-6B0B907F0C37Q26738862-ADA33658-B93D-46B7-9513-0290E1030361Q26740217-7FE33E73-B262-4C70-95C4-86095EDBD3A4Q26741205-CBA16F78-9FEB-4B55-98FB-0A5E00840466Q26743603-6ED99D79-3409-4DAE-889F-55E295113A53Q26743666-9977354B-678A-482F-9329-E2500A691619Q26744542-7D6CFE61-6654-4B4C-9F1E-FB270A8A78FEQ26749329-515CDDE7-4B9E-4013-82E3-C2860E7FECECQ26752478-B36167C3-59A8-47AC-B12C-99BFA6CF0D2BQ26764911-C929575F-CFF3-44FD-8342-922DAD225223Q26765182-C41921FC-7042-42D4-AEDB-EEA978FC024EQ26765210-779DF609-81D2-4721-8E45-04B755297638Q26766689-428BAC2A-9EE5-4059-B96E-2DA2057C5CF9Q26766707-C40B8673-A0B4-485B-8D4B-3F7E845FB245Q26767217-AC8591DE-7FCB-4B40-9C4B-787C7923E47DQ26771776-71F9BD2D-D327-46D1-88FB-35FA2FBAAE7EQ26772299-3C727381-CECA-4796-AC37-3F5410989DD6Q26775437-5AC33E44-B226-46AC-B88B-AD7B362C50C3Q26775654-31325657-69C4-4A6C-B9DD-9565BD28E70EQ26777419-283F2F4D-069E-4AF7-BDC3-EDCA0B3E751AQ26777892-93E4B31A-A191-4F9F-A579-005F34F3B858Q26781798-8CBB3E48-027C-4B9E-A3ED-E8CF875EEBACQ26782585-28A5AE0B-029B-4C8B-A7A3-32E3B54E5549Q26783881-33777848-D122-4D57-8C5E-A9F8B39A489FQ26783895-FFBD86CE-81D1-4B18-8B47-16CD86F3AF39Q26784218-0BC3630E-DED8-43FC-83B9-C45A51768D76Q26784223-2EFD35F6-2392-45F5-8CEB-EB3B2B0663EBQ26784228-1DACD443-F235-4759-841F-49E083F6A9A3Q26784407-9B0AAFD0-AF43-4BCB-8C46-D229C42EB71EQ26784412-5DAA402A-1CEE-4CD8-B844-4DE4F5F80D4DQ26797643-57248873-0F62-4EEB-9419-F45ABC6C0E65Q26799458-72E0FFE6-6F04-4867-BA45-DBDAA172FDABQ26799462-EDB9389B-C5BD-47A5-8427-C9484C1EFCF7Q26801211-F480D10C-AA46-419D-9401-BC36DF75D26A
P2860
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Efficacy and safety of sorafen ...... lind, placebo-controlled trial
@ast
Efficacy and safety of sorafen ...... lind, placebo-controlled trial
@en
type
label
Efficacy and safety of sorafen ...... lind, placebo-controlled trial
@ast
Efficacy and safety of sorafen ...... lind, placebo-controlled trial
@en
prefLabel
Efficacy and safety of sorafen ...... lind, placebo-controlled trial
@ast
Efficacy and safety of sorafen ...... lind, placebo-controlled trial
@en
P2093
P3181
P1433
P1476
Efficacy and safety of sorafen ...... lind, placebo-controlled trial
@en
P2093
Chao-Jung Tsao
Dimitris Voliotis
Hongming Pan
Houjie Liang
Jessie Zou
Jianming Xu
Jiejun Wang
Jifeng Feng
Jun Suk Kim
P3181
P356
10.1016/S1470-2045(08)70285-7
P407
P577
2008-12-16T00:00:00Z